Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.64 USD | -3.13% | -4.13% | -5.11% |
06-25 | Capricor Therapeutics, Inc. Announces for the Treatment of Duchenne Muscular Dystrophy | CI |
06-11 | Sector Update: Health Care Stocks Decline Tuesday Afternoon | MT |
Evolution of the average Target Price on Capricor Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Capricor Therapeutics, Inc.
Oppenheimer | |
HC Wainwright | |
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- CAPR Stock
- Consensus Capricor Therapeutics, Inc.